During erythropoiesis, in response to anemia mediated by hypoxia-inducible factor-2α or exogenous EPO administration, enhancement of ERFE synthesis, which is encoded by the FAM132B gene in erythroblasts, inhibits HEP-25 production, and thus promotes iron acquisition, storage, and utilization.4 This evidence concerns the gene EPO and anemia (phenotype).